UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.585

Sortiert nach

1,3-Dithiole Based Quinoid Systems: Multiply Proaromatic NLO-Phores

Phosphorus, sulfur, and silicon and the related elements, 2005-05, Vol.180 (5-6), p.1473-1474

2005

Volltextzugriff (PDF)

11 DFT and experimental studies of C-C and C-O bond cleavage in ethanol and ethylene glycol on Pt catalysts

Studies in Surface Science and Catalysis, 2003, Vol.145, p.79-84

2003

Volltextzugriff (PDF)

1117 Overtube Assisted EUS With FNA for Esophageal Stenosis

Gastrointestinal endoscopy, 2017-05, Vol.85 (5), p.AB146-AB146

2017

Volltextzugriff (PDF)

12 MONTH FOLLOW-UP OF MEBENDAZOLE THERAPY FOR ONCHOCERCIASIS

The Lancet (British edition), 1981-11, Vol.318 (8254), p.1043-1043

1981

Volltextzugriff (PDF)

12 month follow-up of mebendazole therapy for onchocerciasis

The Lancet (British edition), 1981-11, Vol.2 (8254), p.1043-1043

1981

Volltextzugriff (PDF)

18: Autologous peripheral blood stem cell transplant using busulfan, etoposide, high dose Ara-C, and G-CSF priming as conditioning regimen in patients with acute myeloid leukemia in first complete remission

Biology of blood and marrow transplantation, 2007, Vol.13 (2), p.9-9

2007

Volltextzugriff (PDF)

1933PAutofluorescence: A new marker for identifying cancer stem cells (CSCs) in primary tumors

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1989MO Lurbinectedin (LUR) in combination with pembrolizumab (PBL) in relapsed small cell lung cancer (SCLC): The phase I/II LUPER study

Annals of oncology, 2023-10, Vol.34, p.S1060-S1061

2023

Volltextzugriff (PDF)

20th Anniversary Special Feature: The time for process understanding

Pharmaceutical technology Europe, 2008-05, Vol.20 (5), p.26

2008

Volltextzugriff (PDF)

20th anniversary special feature: the time for process understanding: PAT emphasizes the need to improve pharmaceutical processes through 'quality by design'. Will the system continue to progress? And will it still be part of quality systems during the next 20 years?

Pharmaceutical technology Europe, 2008-05, Vol.20 (5), p.26

2008

Volltextzugriff (PDF)

22: MITOTIC ASYNCHRONY INDUCES A PRO-INFLAMMATORY STATE IN AIRWAY EPITHELIUM

Journal of investigative medicine, 2016-03, Vol.64 (3), p.816

2016

Volltextzugriff (PDF)

230PComplete response (CR) to anthracycline-based chemotherapy using magnetic resonance imaging (MRI) predicts high rates of pathologic complete response (pCR) for triple negative breast cancer (TNBC) patients treated preoperatively with anthracycline and taxane-based regimens

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

260P LUZERN: Phase II trial of niraparib and aromatase inhibitors (AI) for pretreated hormone receptor-positive/HER2-negative germline BRCA-mutated advanced breast cancer

ESMO open, 2024-05, Vol.9, p.103281, Article 103281

2024

Volltextzugriff (PDF)

271P Eribulin (E) plus endocrine therapy (ET) in patients (pts) with HR[+]/HER2[-] metastatic breast cancer (mBC) after progression on previous ET: The REVERT study

Annals of oncology, 2022-09, Vol.33, p.S661-S662

2022

Volltextzugriff (PDF)

2MASS J15491331-3539118: a new low-mass wide companion of the GQ Lup system

Astronomy and astrophysics (Berlin), 2020-03, Vol.635, p.L1

2020

Volltextzugriff (PDF)

2MASS J15491331-3539118: a new low-mass wide companionof the GQ Lup system

Astronomy and astrophysics (Berlin), 2020-02, Vol.635

2020

Volltextzugriff (PDF)

3D Printed Models for Planning and Intraoperative Assistance in Complex Hepatic Surgeries

HPB (Oxford, England), 2021, Vol.23, p.S204-S205

2021

Volltextzugriff (PDF)

468: Impact of CFTR modulators on antibiotic susceptibility and virulence of Pseudomonas aeruginosa and Staphylococcus aureus

Journal of cystic fibrosis, 2021-11, Vol.20, p.S221

2021

Volltextzugriff (PDF)

4CPS-046 Pharmaceutical interventions in antimicrobial treatment in a 150-bed hospital

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A89-A89

2019

Volltextzugriff (PDF)

4CPS-115 Development and implementation of a review programme assisted by the pharmacist to improve the adequacy of treatment in polymedicated patients in hospital outpatient setting

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A60-A60

2023

Volltextzugriff (PDF)

4CPS-119 Pneumonology-pharmacy collaboration in the pharmacotherapeutic optimisation of monoclonal antibodies in patients with severe uncontrolled asthma

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A62-A63

2023

Volltextzugriff (PDF)

4CPS-170 Evaluation of zoledronic acid in the treatment of bone diseases with high risk of fractures

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A121-A121

2018

Volltextzugriff (PDF)

4CPS-194 Descriptive analysis of active clinical trials managed in a pharmacy department of a tertiary hospital

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A132-A133

2018

Volltextzugriff (PDF)

4CPS-314 3 day course of low dose subcutaneous anakinra in patients with refractory moderate–severe COVID-19: a proof-of-concept study

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A71-A72

2021

Volltextzugriff (PDF)

51O The European Prospective Investigation into Cancer and nutrition cohort (EPIC): A gateway to rare cancer epidemiological research – Insights from the EPIC Rare Cancers Working Group

ESMO open, 2024-03, Vol.9, p.102440, Article 102440

2024

Volltextzugriff (PDF)

1 – 25 von 2.585

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.193)
Mit Volltextzugriff
(2.297)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.458)
Life Sciences & Biomedicine
(918)
Humans
(621)
Physical Sciences
(406)
Male
(380)
Female
(335)
Technology
(279)
Biological And Medical Sciences
(218)
Middle Aged
(210)
Adult
(190)
Exact Sciences And Technology
(188)
Aged
(163)
Animals
(156)
Chemistry
(142)
Astronomy & Astrophysics
(131)
Materials Science
(129)
Physics
(125)
Engineering
(123)
Medical Sciences
(123)
Fundamental And Applied Biological Sciences. Psychology
(105)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

1,3-Dithiole Based Quinoid Systems: Multiply Proaromatic NLO-Phores

11 DFT and experimental studies of C-C and C-O bond cleavage in ethanol and ethylene glycol on Pt catalysts

1117 Overtube Assisted EUS With FNA for Esophageal Stenosis

12 MONTH FOLLOW-UP OF MEBENDAZOLE THERAPY FOR ONCHOCERCIASIS

12 month follow-up of mebendazole therapy for onchocerciasis

18: Autologous peripheral blood stem cell transplant using busulfan, etoposide, high dose Ara-C, and G-CSF priming as conditioning regimen in patients with acute myeloid leukemia in first complete remission

1933PAutofluorescence: A new marker for identifying cancer stem cells (CSCs) in primary tumors

1989MO Lurbinectedin (LUR) in combination with pembrolizumab (PBL) in relapsed small cell lung cancer (SCLC): The phase I/II LUPER study

20th Anniversary Special Feature: The time for process understanding

20th anniversary special feature: the time for process understanding: PAT emphasizes the need to improve pharmaceutical processes through 'quality by design'. Will the system continue to progress? And will it still be part of quality systems during the next 20 years?

22: MITOTIC ASYNCHRONY INDUCES A PRO-INFLAMMATORY STATE IN AIRWAY EPITHELIUM

230PComplete response (CR) to anthracycline-based chemotherapy using magnetic resonance imaging (MRI) predicts high rates of pathologic complete response (pCR) for triple negative breast cancer (TNBC) patients treated preoperatively with anthracycline and taxane-based regimens

260P LUZERN: Phase II trial of niraparib and aromatase inhibitors (AI) for pretreated hormone receptor-positive/HER2-negative germline BRCA-mutated advanced breast cancer

271P Eribulin (E) plus endocrine therapy (ET) in patients (pts) with HR[+]/HER2[-] metastatic breast cancer (mBC) after progression on previous ET: The REVERT study

2MASS J15491331-3539118: a new low-mass wide companion of the GQ Lup system

2MASS J15491331-3539118: a new low-mass wide companionof the GQ Lup system

3D Printed Models for Planning and Intraoperative Assistance in Complex Hepatic Surgeries

468: Impact of CFTR modulators on antibiotic susceptibility and virulence of Pseudomonas aeruginosa and Staphylococcus aureus

4CPS-046 Pharmaceutical interventions in antimicrobial treatment in a 150-bed hospital

4CPS-115 Development and implementation of a review programme assisted by the pharmacist to improve the adequacy of treatment in polymedicated patients in hospital outpatient setting

4CPS-119 Pneumonology-pharmacy collaboration in the pharmacotherapeutic optimisation of monoclonal antibodies in patients with severe uncontrolled asthma

4CPS-170 Evaluation of zoledronic acid in the treatment of bone diseases with high risk of fractures

4CPS-194 Descriptive analysis of active clinical trials managed in a pharmacy department of a tertiary hospital

4CPS-314 3 day course of low dose subcutaneous anakinra in patients with refractory moderate–severe COVID-19: a proof-of-concept study

51O The European Prospective Investigation into Cancer and nutrition cohort (EPIC): A gateway to rare cancer epidemiological research – Insights from the EPIC Rare Cancers Working Group

Suchergebnisse filtern